Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Kiora Pharmaceuticals, Inc. - Common Stock (NQ: KPRX ) 3.568 +0.048 (+1.37%) Streaming Delayed Price Updated: 3:58 PM EST, Nov 7, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Kiora Pharmaceuticals, Inc. - Common Stock Lytham Partners Announces KOL Panels and Participating Companies for its Fall 2024 Investor Conference September 30, 2024 Phoenix, Arizona and New York, New York--(Newsfile Corp. - September 30, 2024) - Lytham... Via Newsfile Lytham Partners Spring 2024 Investor Conference Starts Tomorrow, May 30, 2024 May 29, 2024 Phoenix, Arizona and New York, New York--(Newsfile Corp. - May 29, 2024) - Lytham Partners, a leading investor relations and... Via Newsfile Kiora Pharmaceuticals Reports First Quarter Results; Update on Pipeline of Drugs Targeting Retinal Disease May 10, 2024 Phase 2 trial for KIO-301 for the treatment of retinitis pigmentosa, in partnership with Théa Open Innovation, expected to be... Via Newsfile AAO Late-Breaking: Kiora's Small Molecule Photoswitch Demonstrates Meaningful Vision Improvements in Blind Patients with Retinitis Pigmentosa November 04, 2023 Topline Phase I/II First-in-Human Results Presented at AAO 2023Significant improvement in visual field, in concordance with trended improvements in visual... Via Newsfile Shares of Kiora Pharmaceuticals Inc. (KPRX) Rise to a New 52-Week High September 27, 2022 Via Investor Brand Network Kiora Pharmaceuticals Taps B2i Digital to Deploy Data-Driven Investor Awareness Program August 22, 2023 Encinitas, California--(Newsfile Corp. - August 22, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), a clinical-stage biotechnology company developing novel therapies... Via Newsfile Life Science Investor Forum: Presentations Now Available for Online Viewing June 23, 2023 Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com From Virtual Investor Conferences Via GlobeNewswire Life Science Investor Forum Agenda Announced for June 22nd June 20, 2023 Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com From Virtual Investor Conferences Via GlobeNewswire Stonegate Healthcare Reviews Retinitis Pigmentosa December 14, 2022 Dallas, Texas--(Newsfile Corp. - December 14, 2022) - Stonegate Healthcare has published a new... Via Newsfile Battling Blindness: Virtual Investor Event on Treatments for Retinitis Pigmentosa to Be Held October 19; Panelists include Kiora Pharmaceuticals, Foundation Fighting Blindness, and Retinal Surgeon Christine Kay, M.D. September 28, 2022 Dallas, Texas--(Newsfile Corp. - September 28, 2022) - Stonegate Capital Partners will host a... Via Newsfile Kiora Pharmaceuticals, Inc. f.k.a. EyeGate Pharmaceuticals, Inc. (NASDAQ:KPRX, Formerly NASDAQ:EYEG) Investor Notice: Investigation February 15, 2022 San Diego, CA -- (SBWIRE) -- 02/15/2022 -- An investigation was announced for investors of Kiora Pharmaceuticals, Inc. f.k.a. EyeGate Pharmaceuticals, Inc. (NASDAQ:KPRX, formerly NASDAQ:EYEG) shares... Via SBWire Kiora Pharmaceuticals, Inc. f.k.a. EyeGate Pharmaceuticals, Inc. (NASDAQ:KPRX, Formerly NASDAQ:EYEG) Investor Notice: Investigation Announced December 15, 2021 San Diego, CA -- (SBWIRE) -- 12/15/2021 -- An investigation was announced for investors of Kiora Pharmaceuticals, Inc. f.k.a. EyeGate Pharmaceuticals, Inc. (NASDAQ:KPRX, formerly NASDAQ:EYEG) shares... Via SBWire NASDAQ:KPRX, Formerly NASDAQ:EYEG Investor Alert: Investigation over Potential Wrongdoing at Kiora Pharmaceuticals, Inc. f.k.a. EyeGate Pharmaceuticals, Inc. December 01, 2021 San Diego, CA -- (SBWIRE) -- 12/01/2021 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Kiora Pharmaceuticals, Inc f.k.a. EyeGate... Via SBWire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
